John Hale, PhD

John Hale, PhD

Company: BLIS Technologies

Job title: Chief Technology Officer


Micrococcus luteus BLIS Q24™ – Development of a Novel Skin Probiotic Strain & Formulation 3:35 pm

Characterising a new probiotic strain for skin health applications Formulating BLIS Q24™ into an appropriate topical delivery system The emerging evidence base supporting BLIS Q24™Read more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.